145 related articles for article (PubMed ID: 25901613)
1. Ultra-low-dose recombinant human bone morphogenetic protein-2 for 3-level anterior cervical diskectomy and fusion.
Pourtaheri S; Hwang K; Faloon M; Issa K; Mease SJ; Mangels D; Sinha K; Emami A
Orthopedics; 2015 Apr; 38(4):241-5. PubMed ID: 25901613
[TBL] [Abstract][Full Text] [Related]
2. Multilevel anterior cervical discectomy and fusion with and without rhBMP-2: a comparison of dysphagia rates and outcomes in 150 patients.
Lu DC; Tumialán LM; Chou D
J Neurosurg Spine; 2013 Jan; 18(1):43-9. PubMed ID: 23157278
[TBL] [Abstract][Full Text] [Related]
3. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2.
Vaidya R; Carp J; Sethi A; Bartol S; Craig J; Les CM
Eur Spine J; 2007 Aug; 16(8):1257-65. PubMed ID: 17387522
[TBL] [Abstract][Full Text] [Related]
4. Analysis of prevertebral soft-tissue swelling and dysphagia in multilevel anterior cervical discectomy and fusion with recombinant human bone morphogenetic protein-2 in patients at risk for pseudarthrosis.
Stachniak JB; Diebner JD; Brunk ES; Speed SM
J Neurosurg Spine; 2011 Feb; 14(2):244-9. PubMed ID: 21184639
[TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of anterior cervical discectomy and fusion with polyetheretherketone spacer and recombinant human bone morphogenetic protein-2: a review of 200 patients.
Tumialán LM; Pan J; Rodts GE; Mummaneni PV
J Neurosurg Spine; 2008 Jun; 8(6):529-35. PubMed ID: 18518673
[TBL] [Abstract][Full Text] [Related]
6. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
Lee DD; Kim JY
J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904
[TBL] [Abstract][Full Text] [Related]
7. Comparison of rhBMP-2 versus Autogenous Iliac Crest Bone Graft for 2-Level Anterior Cervical Discectomy and Fusion for Cervical Spondylotic Myelopathy.
Tan B; Wang H; Dong J; Yuan Z; Wang D; Wang F
Med Sci Monit; 2015 Oct; 21():3159-65. PubMed ID: 26479708
[TBL] [Abstract][Full Text] [Related]
8. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?
Hiremath GK; Steinmetz MP; Krishnaney AA
Spine (Phila Pa 1976); 2009 Apr; 34(9):885-9. PubMed ID: 19531997
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human bone morphogenetic protein-2 versus iliac crest bone graft in anterior cervical discectomy and fusion: Dysphagia and dysphonia rates in the early postoperative period with review of the literature.
Riederman BD; Butler BA; Lawton CD; Rosenthal BD; Balderama ES; Bernstein AJ
J Clin Neurosci; 2017 Oct; 44():180-183. PubMed ID: 28716569
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
[TBL] [Abstract][Full Text] [Related]
11. Usage of recombinant human bone morphogenetic protein in cervical spine procedures: analysis of the MarketScan longitudinal database.
Cole T; Veeravagu A; Jiang B; Ratliff JK
J Bone Joint Surg Am; 2014 Sep; 96(17):1409-16. PubMed ID: 25187578
[TBL] [Abstract][Full Text] [Related]
12. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.
Glassman SD; Gum JL; Crawford CH; Shields CB; Carreon LY
Spine J; 2011 Jun; 11(6):522-6. PubMed ID: 20598649
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion.
Shields LB; Raque GH; Glassman SD; Campbell M; Vitaz T; Harpring J; Shields CB
Spine (Phila Pa 1976); 2006 Mar; 31(5):542-7. PubMed ID: 16508549
[TBL] [Abstract][Full Text] [Related]
14. Dose Adjustment Associated Complications of Bone Morphogenetic Protein: A Longitudinal Assessment.
De Stefano FA; Elarjani T; Burks JD; Burks SS; Levi AD
World Neurosurg; 2021 Dec; 156():e64-e71. PubMed ID: 34530148
[TBL] [Abstract][Full Text] [Related]
15. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
[TBL] [Abstract][Full Text] [Related]
16. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.
Villavicencio AT; Burneikiene S
Spine J; 2016 Oct; 16(10):1208-1213. PubMed ID: 27343729
[TBL] [Abstract][Full Text] [Related]
17. Complications in Adult Patients with Down Syndrome Undergoing Cervical Spine Surgery Using Current Instrumentation Techniques and rhBMP-2: A Long-Term Follow-Up.
Siemionow K; Hansdorfer M; Janusz P; Mardjetko S
J Neurol Surg A Cent Eur Neurosurg; 2017 Mar; 78(2):113-123. PubMed ID: 27448197
[No Abstract] [Full Text] [Related]
18. Anterior Cervical Discectomy and Fusion: Comparison of Fusion, Dysphagia, and Complication Rates Between Recombinant Human Bone Morphogenetic Protein-2 and Beta-Tricalcium Phosphate.
Lovasik BP; Holland CM; Howard BM; Baum GR; Rodts GE; Refai D
World Neurosurg; 2017 Jan; 97():674-683.e1. PubMed ID: 27989984
[TBL] [Abstract][Full Text] [Related]
19. Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein.
Boakye M; Mummaneni PV; Garrett M; Rodts G; Haid R
J Neurosurg Spine; 2005 May; 2(5):521-5. PubMed ID: 15945426
[TBL] [Abstract][Full Text] [Related]
20. Cervical corpectomy with ultra-low-dose rhBMP-2 in high-risk patients: 5-year outcomes.
Pourtaheri S; Emami A; Hwang K; Allert J; Brothers A; Issa K; Mont MA
Orthopedics; 2013 Dec; 36(12):931-5. PubMed ID: 24579211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
